About Curia
Curia is a company based in Burlington (United States) founded in 1999 was acquired by Curia in June 2010. It operates as a Professional Services and Managed Services. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
- Headquarter Burlington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curia Global, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery are provided.
Generic API manufacturing services are comprehensively offered.
Biologics discovery and manufacturing services are delivered.
Sterile drug product development services are provided.
Funding Insights of Curia
Investors in Curia
Curia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug research, development, testing, and consulting services are provided.
|
Locked | Locked | Locked |
Investor details for Curia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Investment portfolio details for Curia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curia
Detailed financials for Curia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curia Comparisons
Peer comparison for Curia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curia
Detailed competitors of Curia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Curia is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience. Services are provided across small molecules, generic APIs, and biologics, supporting drug discovery, development, and manufacturing. Operations are conducted through an integrated network of 23 facilities across North America, Europe, and India. Solutions are tailored to meet the needs of biopharma companies of all sizes, ensuring flexibility and scalability. Advanced technologies and scientific expertise are utilized to accelerate the delivery of therapies to patients.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia has 1 investor. Key investors include Curia.